126 related articles for article (PubMed ID: 15577545)
1. Infection with concurrent multiple hepatitis C virus genotypes is associated with faster HIV disease progression.
van Asten L; Prins M
AIDS; 2004 Nov; 18(17):2319-24. PubMed ID: 15577545
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C and progression of HIV disease.
Sulkowski MS; Moore RD; Mehta SH; Chaisson RE; Thomas DL
JAMA; 2002 Jul; 288(2):199-206. PubMed ID: 12095384
[TBL] [Abstract][Full Text] [Related]
3. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; De Luca A; Puoti M; Petrelli E; Carnevale G; Rizzardini G; Grossi PA; Viganò P; Moioli MC; Carletti F; Solmone M; Ippolito G; Monforte AD; ;
Clin Infect Dis; 2005 Jun; 40(12):e101-9. PubMed ID: 15909251
[TBL] [Abstract][Full Text] [Related]
4. The effect of hepatitis C on progression to AIDS before and after highly active antiretroviral therapy.
Dorrucci M; Valdarchi C; Suligoi B; Zaccarelli M; Sinicco A; Giuliani M; Vlahov D; Pezzotti P; Rezza G
AIDS; 2004 Nov; 18(17):2313-8. PubMed ID: 15577544
[TBL] [Abstract][Full Text] [Related]
5. Does hepatitis C virus co-infection accelerate clinical and immunological evolution of HIV-infected patients?
Piroth L; Duong M; Quantin C; Abrahamowicz M; Michardiere R; Aho LS; Grappin M; Buisson M; Waldner A; Portier H; Chavanet P
AIDS; 1998 Mar; 12(4):381-8. PubMed ID: 9520167
[TBL] [Abstract][Full Text] [Related]
6. The impact of hepatitis C virus coinfection on HIV progression before and after highly active antiretroviral therapy.
Klein MB; Lalonde RG; Suissa S
J Acquir Immune Defic Syndr; 2003 Jul; 33(3):365-72. PubMed ID: 12843748
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus coinfection and HIV load, CD4+ cell percentage, and clinical progression to AIDS or death among HIV-infected women: Women and Infants Transmission Study.
Hershow RC; O'Driscoll PT; Handelsman E; Pitt J; Hillyer G; Serchuck L; Lu M; Chen KT; Yawetz S; Pacheco S; Davenny K; Adeniyi-Jones S; Thomas DL
Clin Infect Dis; 2005 Mar; 40(6):859-67. PubMed ID: 15736020
[TBL] [Abstract][Full Text] [Related]
8. Is hepatitis C virus co-infection associated with survival in HIV-infected patients treated by combination antiretroviral therapy?
Rancinan C; Neau D; Savès M; Lawson-Ayayi S; Bonnet F; Mercié P; Dupon M; Couzigou P; Dabis F; Chêne G;
AIDS; 2002 Jul; 16(10):1357-62. PubMed ID: 12131212
[TBL] [Abstract][Full Text] [Related]
9. Effect of hepatitis C infection on progression of HIV disease and early response to initial antiretroviral therapy.
Sullivan PS; Hanson DL; Teshale EH; Wotring LL; Brooks JT
AIDS; 2006 May; 20(8):1171-9. PubMed ID: 16691069
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C infection on immune recovery in HIV-positive patients on successful HAART: the role of genotype 3.
Seminari E; Tinelli C; Ravasi G; Ripamonti D; Ladisa N; Marino N; Sighinolfi L; Mondello P; Migliorino M; Carosi G; Maserati R;
Curr HIV Res; 2010 Apr; 8(3):186-93. PubMed ID: 20163342
[TBL] [Abstract][Full Text] [Related]
11. Clinical and virological characteristics of hepatitis B or C virus co-infection with HIV in Indonesian patients.
Anggorowati N; Yano Y; Heriyanto DS; Rinonce HT; Utsumi T; Mulya DP; Subronto YW; Hayashi Y
J Med Virol; 2012 Jun; 84(6):857-65. PubMed ID: 22499006
[TBL] [Abstract][Full Text] [Related]
12. Risk of hepatitis-related mortality increased among hepatitis C virus/HIV-coinfected drug users compared with drug users infected only with hepatitis C virus: a 20-year prospective study.
Smit C; van den Berg C; Geskus R; Berkhout B; Coutinho R; Prins M
J Acquir Immune Defic Syndr; 2008 Feb; 47(2):221-5. PubMed ID: 18223361
[TBL] [Abstract][Full Text] [Related]
13. HCV genotype analysis in HCV-HIV-co-infected Puerto Ricans who are injecting drug users: undetermined and mixed infections.
Ríos-Olivares E; Yamamura Y; Gómez MA; Guzmán L; Rodríguez N; Fernández D; Hunter Mellado R
Cell Mol Biol (Noisy-le-grand); 2001 Sep; 47(6):1017-24. PubMed ID: 11785651
[TBL] [Abstract][Full Text] [Related]
14. Differences in Response to Antiretroviral Therapy by Sex and Hepatitis C Infection Status.
Marcus JL; Leyden WA; Chao CR; Xu L; Quesenberry CP; Tien PC; Klein DB; Towner WJ; Horberg MA; Silverberg MJ
AIDS Patient Care STDS; 2015 Jul; 29(7):370-8. PubMed ID: 26061798
[TBL] [Abstract][Full Text] [Related]
15. Epidemiological, immunological and virological characteristics, and disease progression of HIV-1/HCV-co-infected patients from a southern Brazilian population.
Reiche EM; Bonametti AM; Morimoto HK; Morimoto AA; Wiechemann SL; Matsuo T; Vissoci Reiche F; Vogler IH
Int J Mol Med; 2008 Mar; 21(3):387-95. PubMed ID: 18288387
[TBL] [Abstract][Full Text] [Related]
16. Impact of chronic hepatitis C infection on outcomes of patients with an advanced stage of HIV-1 infection in an area of low prevalence of co-infection.
Hung CC; Chen MY; Hsieh SM; Hsiao CF; Sheng WH; Chang SC
Int J STD AIDS; 2005 Jan; 16(1):42-8. PubMed ID: 15705272
[TBL] [Abstract][Full Text] [Related]
17. Influence of genotype 3 hepatitis C coinfection on liver enzyme elevation in HIV-1-positive patients after commencement of a new highly active antiretroviral regimen: results from the EPOKA-MASTER Cohort.
Torti C; Lapadula G; Puoti M; Casari S; Uccelli MC; Cristini G; Bella D; Pastore G; Ladisa N; Minoli L; Sotgiu G; Caputo SL; Bonora S; Carosi G
J Acquir Immune Defic Syndr; 2006 Feb; 41(2):180-5. PubMed ID: 16394850
[TBL] [Abstract][Full Text] [Related]
18. Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy.
Rockstroh JK; Mocroft A; Soriano V; Tural C; Losso MH; Horban A; Kirk O; Phillips A; Ledergerber B; Lundgren J;
J Infect Dis; 2005 Sep; 192(6):992-1002. PubMed ID: 16107951
[TBL] [Abstract][Full Text] [Related]
19. Survival in HIV-infected patients is associated with hepatitis C virus infection and injecting drug use since the use of highly active antiretroviral therapy in the Lyon observational database.
Voirin N; Trépo C; Miailhes P; Touraine JL; Chidiac C; Peyramond D; Livrozet JM; Ritter J; Chevallier P; Fabry J; Allard R; Vanhems P
J Viral Hepat; 2004 Nov; 11(6):559-62. PubMed ID: 15500557
[TBL] [Abstract][Full Text] [Related]
20. [The prevalence of hepatitis C virus (HCV) subtypes in Chinese HIV-1/HCV co-infected individuals].
Liu J; Yang Y; Gong JL; Zhang ZN; Zhang M; Wang YN; Jiang YJ; Qi ZT; Pan QC; Zhong P; Shang H
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Jul; 30(7):663-7. PubMed ID: 19957585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
